News
Exciting moment! We’ve been honored with the 2024 CDMO Leadership Awards in all six core categories: Capabilities, Compatibility, Expertise, Quality, Reliability, and Service, again! Dr.…
Exciting moment! We’ve been honored with the 2024 CDMO Leadership Awards in all six core categories: Capabilities, Compatibility, Expertise, Quality, Reliability, and Service, again! Dr. Jinling Chen, our Senior Vice President and Head of Pharmaceutical Development and Manufacturing at STA, accepted the trophy last night at the CDMO Leadership Awards ceremony in NYC. This is the 10th time we received the CDMO Leadership Awards. We sincerely thank our global partners for their ongoing trust and confidence in our capabilities, which fuels our commitment to innovation and excellence.
Keep reading
Shanghai, China – April 1, 2025 — WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life sciences…
Couvet, Switzerland – November 14, 2024 – WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life…
First operational building dedicated to API development for oligonucleotides, peptides, and complex synthetic conjugates.
How can we help?
Tell us where your molecule is today — discovery, CMC, or commercial supply — and we will map the fastest credible route to patients.
Small molecule projects? WuXi STA